Replies to post #93543 on Biotech Values

[DewDiligence]

ITMN:

There wasn't much detail on how [the second-generation PI is] differentiated other then better Pk.

The main “differentiation” is that, unlike ITMN-191, Roche is actually serious about developing the second-generation compound :- )